Hilary MacQueen

Has grant

Professor in Health Sciences

Open University
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Optimising a novel co-culture system to study cardiomyocyte-epicardial adipocyte interactions

Open Date: 2018-03-01

Close Date: 2019-03-01

Articles (2)

Year:

2026

Infection with Shigella bacteria is one of the leading causes of diarrhoeal disease globally, with significant burden in low- and middle-income countries and rising incidence in high-income settings. Effective serotyping is essential for surveillance, outbreak investigation, vaccine targeting, and can inform clinical management. Current discriminative approaches, such as seroagglutination and whole genome sequencing, are constrained by cross-reactivity, infrastructure requirements, and cost. Here, we present the development of a nine-target multiplex PCR lateral flow device assay for the rapid, accurate identification of vaccine-prioritised S. flexneri serotypes 1b, 2a, and 3a, and S. sonnei , as well as clinically relevant antimicrobial resistance genes. Validation using 138 DNA samples from clinical Shigella isolates showed 97.8% sensitivity and 100% specificity at the species level, performing comparably to in silico genomic prediction tools. Serotype classifications interpreted from the PCR assay also successfully aligned with the temporal and geographic trends observed in a large multi-country clinical dataset ( n = 1,074), supporting its utility for temporospatial surveillance. To facilitate field-deployment of the PCR assay, we integrated an oligo-chromatographic dipstick method, enabling a simple, gel-free readout without need for specialised equipment. This molecular dipstick assay provides a practical and scalable solution for Shigella serotyping and antimicrobial resistance profiling in support of vaccine implementation and surveillance efforts.

Year:

2025

Collaborators (5)

Xiaoliang Ba

University of Cambridge

UNITED KINGDOM
View details

Mark A. Holmes

University of Cambridge

UNITED KINGDOM
View details

Kate Baker

Professor of Infectious Disease

University of Cambridge

UNITED KINGDOM
View details

Ankur Mutreja

University of Cambridge

UNITED KINGDOM
View details

Sushila Rigas

Open University

UNITED KINGDOM
View details